Shelter Pharma

{
  "main_header": {
    "sid": 10038980,
    "name": "Shelter Pharma",
    "stock_name": "Shelter Pharma",
    "full_name": "Shelter Pharma Ltd",
    "name_url": "stocks-analysis/shelter-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "40.10",
    "chg": -1.74,
    "chgp": "-4.16%",
    "dir": -1,
    "prev_price": "41.84",
    "mcapval": "68.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543963,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013V01011",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": 3000,
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shelter-pharma-10038980-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Shelter Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shelter-pharma-fallingrising-3757871",
        "imagepath": "",
        "date": "2025-12-13 01:24:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Shelter Pharma’s shares opened with a gap down, immediately trading at ₹36.01 and maintaining this level throughout the day, marking the day’s low as well. The stock is now trading just 0.86% above its 52-week low of ₹35.70, signalling persistent weakness. This proximity to the annual low highlights the pressure the stock has been under in recent months.</p>\n<p>Comparatively, the benchmark Sensex has shown resilience, gaining 0.95% over the past month and 9.12% year-to-date, while Shelter Pharma has declined sharply by 14.38% over the last month and 35.45% since the start of the year. Over the one-year horizon, the stock has fallen 33.55%, whereas the Sensex has appreciated by 4.89%. This stark divergence emphasises the stock’s relativ..."
      },
      {
        "title": "Why is Shelter Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shelter-pharma-fallingrising-3699936",
        "imagepath": "",
        "date": "2025-11-13 23:57:35",
        "description": "As of 13-Nov, Shelter Pharma Ltd is experiencing a decline in its stock price, currently at 41.25, which represents a decrease of 0.81 or 1.93%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 7.72% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. While there has been a slight increase in investor participation with a delivery volume rise of 6.06% against the 5-day average, the overall performance remains negative, with the stock down 0.84% over the past month and 26.06% year-to-date.\n\nIn the broader market context, Shelter Pharma's recent performance contrasts with the benchmark Sensex, which has gained 1.40% over the past week and 2.61% over the past month. This underperformance highlights the stock's struggles relative to the mar..."
      },
      {
        "title": "How has been the historical performance of Shelter Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-shelter-pharma-3694338",
        "imagepath": "",
        "date": "2025-11-12 23:35:19",
        "description": "Answer:\nThe historical performance of Shelter Pharma shows a consistent growth trajectory in net sales and profitability over the years.\n\nBreakdown:\nShelter Pharma's net sales have steadily increased from INR 30.06 crore in March 2022 to INR 50.66 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 50.66 crore in March 2025, up from INR 30.06 crore in March 2022. The company's total expenditure also grew, amounting to INR 40.59 crore in March 2025, compared to INR 27.38 crore in March 2022. Operating profit (PBDIT) has shown significant improvement, rising from INR 2.68 crore in March 2022 to INR 10.08 crore in March 2025, reflecting an operating profit margin of 19.88% in the latest fiscal year. Profit before tax increased from INR 2.51 crore in March 2022 to INR 9.68 crore in March 2025, with profit after tax also rising from INR 1.84 crore to INR 7.24 cr..."
      },
      {
        "title": "Why is Shelter Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shelter-pharma-fallingrising-3687417",
        "imagepath": "",
        "date": "2025-11-11 00:14:31",
        "description": "As of 10-Nov, Shelter Pharma Ltd's stock price is rising, currently at Rs 44.10, reflecting an increase of Rs 2.24 or 5.35%. The stock has shown a positive performance today, outperforming its sector by 4.3%, and has been on a consecutive gain for the last two days, accumulating a total return of 7.98% during this period. It opened with a gain of 2.7% and reached an intraday high of Rs 46.51, which is an increase of 11.11%. Despite this upward movement, the stock has a year-to-date decline of 20.95% and a one-year decline of 18.38%, indicating a challenging longer-term performance. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nBroader Market Context: In the short term, Shelter Pharma's stock has outperformed the benchmark Sensex, which has seen a decline of 0.53% over the past week while Shelter Pharma has increased by 6.27%..."
      }
    ],
    "total": 56,
    "sid": "10038980",
    "stock_news_url": "https://www.marketsmojo.com/news/shelter-pharma-10038980"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Feb-2026",
      "details": "Shelter Pharma Limited Launch a new Products Fitkick Pro with Three Different Flavors",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "27-Jan-2026",
      "details": "Intimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclousure Requirements) Regulation 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "23-Jan-2026",
      "details": "Intimation with Regards to Shelter Pharma Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclousure Requirement) Regulation 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shelter Pharma Ltd has declared <strong>3%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Shelter Pharma falling/rising?

2025-12-13 01:24:17

Recent Price Movement and Market Context

Shelter Pharma’s shares opened with a gap down, immediately trading at ₹36.01 and maintaining this level throughout the day, marking the day’s low as well. The stock is now trading just 0.86% above its 52-week low of ₹35.70, signalling persistent weakness. This proximity to the annual low highlights the pressure the stock has been under in recent months.

Comparatively, the benchmark Sensex has shown resilience, gaining 0.95% over the past month and 9.12% year-to-date, while Shelter Pharma has declined sharply by 14.38% over the last month and 35.45% since the start of the year. Over the one-year horizon, the stock has fallen 33.55%, whereas the Sensex has appreciated by 4.89%. This stark divergence emphasises the stock’s relativ...

Read full news article

Why is Shelter Pharma falling/rising?

2025-11-13 23:57:35

As of 13-Nov, Shelter Pharma Ltd is experiencing a decline in its stock price, currently at 41.25, which represents a decrease of 0.81 or 1.93%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 7.72% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. While there has been a slight increase in investor participation with a delivery volume rise of 6.06% against the 5-day average, the overall performance remains negative, with the stock down 0.84% over the past month and 26.06% year-to-date. In the broader market context, Shelter Pharma's recent performance contrasts with the benchmark Sensex, which has gained 1.40% over the past week and 2.61% over the past month. This underperformance highlights the stock's struggles relative to the mar...

Read full news article

How has been the historical performance of Shelter Pharma?

2025-11-12 23:35:19

Answer: The historical performance of Shelter Pharma shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Shelter Pharma's net sales have steadily increased from INR 30.06 crore in March 2022 to INR 50.66 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 50.66 crore in March 2025, up from INR 30.06 crore in March 2022. The company's total expenditure also grew, amounting to INR 40.59 crore in March 2025, compared to INR 27.38 crore in March 2022. Operating profit (PBDIT) has shown significant improvement, rising from INR 2.68 crore in March 2022 to INR 10.08 crore in March 2025, reflecting an operating profit margin of 19.88% in the latest fiscal year. Profit before tax increased from INR 2.51 crore in March 2022 to INR 9.68 crore in March 2025, with profit after tax also rising from INR 1.84 crore to INR 7.24 cr...

Read full news article

Why is Shelter Pharma falling/rising?

2025-11-11 00:14:31

As of 10-Nov, Shelter Pharma Ltd's stock price is rising, currently at Rs 44.10, reflecting an increase of Rs 2.24 or 5.35%. The stock has shown a positive performance today, outperforming its sector by 4.3%, and has been on a consecutive gain for the last two days, accumulating a total return of 7.98% during this period. It opened with a gain of 2.7% and reached an intraday high of Rs 46.51, which is an increase of 11.11%. Despite this upward movement, the stock has a year-to-date decline of 20.95% and a one-year decline of 18.38%, indicating a challenging longer-term performance. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader Market Context: In the short term, Shelter Pharma's stock has outperformed the benchmark Sensex, which has seen a decline of 0.53% over the past week while Shelter Pharma has increased by 6.27%...

Read full news article

View All News